Targeting the endothelial glycocalyx in acute critical illness as a challenge for clinical and laboratory medicine

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F17%3A10364165" target="_blank" >RIV/00216208:11140/17:10364165 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11150/17:10364165 RIV/00179906:_____/17:10364165 RIV/00669806:_____/17:10364165 RIV/44555601:13450/17:43894533

Result on the web

<a href="http://dx.doi.org/10.1080/10408363.2017.1379943" target="_blank" >http://dx.doi.org/10.1080/10408363.2017.1379943</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1080/10408363.2017.1379943" target="_blank" >10.1080/10408363.2017.1379943</a>

Result language

angličtina

Original language name

Targeting the endothelial glycocalyx in acute critical illness as a challenge for clinical and laboratory medicine

Original language description

The purpose of this manuscript is to review the role of endothelial glycocalyx (EG) in the field of critical and perioperative medicine and to discuss possible future directions for investigations in this area. Under physiological conditions, EG has several well-defined functions aimed to prevent the disruption of vessel wall integrity. Under pathological conditions, the EG represent one of the earliest sites of injury during inflammation. EG structure and function distortion contribute to organ dysfunction related to sepsis, trauma, or global ischemia of any origin. Discovering new therapeutic approaches (either pharmacological or non-pharmacological) aimed to protect the EG against injury represents a promising direction in clinical medicine. Further, the currently-used common interventions in the acutely ill-fluids, blood products, nutritional support, organ-supporting techniques (e.g. continuous renal replacement therapy, extracorporeal circulation), temperature modulation and many others-should be re-evaluated during acute illness in terms of their EG &quot;friendliness&quot;. To assess new therapies that protect the EG, or to evaluate the effect of currently-used interventions on EG integrity, a relevant marker or method to determine EG damage is needed. Such marker or method should be available to clinicians within hours, preferably in the form of a point-of-care test at the bedside. Collaborative research between clinical disciplines and laboratory medicine is warranted, and targeting the EG represents major challenges for both. (C) 2017 Informa UK Limited, trading as Taylor &amp; Francis Group.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30223 - Anaesthesiology

Project

<a href="/en/project/NV15-31881A" target="_blank" >NV15-31881A: Alterations of glycocalyx in critical illness and during major surgery and approaches for glycocalyx protection</a><br>

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2017

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Critical Reviews in Clinical Laboratory Sciences

ISSN

1040-8363

e-ISSN

—

Volume of the periodical

54

Issue of the periodical within the volume

5

Country of publishing house

US - UNITED STATES

Number of pages

15

Pages from-to

343-357

UT code for WoS article

000414146600004

EID of the result in the Scopus database

2-s2.0-85030843144